Market Overview:
Bioanalysis is a branch of analytical chemistry that deals with biological samples for analysis of measurement of biological molecules, DNA, large molecules, and others. Bioanalytical services are specifically applied to toxicology, pharmacology studies, bioequivalence studies, along with pharmacokinetic and bioavailability studies in animals of humans. Bioanalytical services are offered for every phase of drug development, from discovery to clinical development phases. The bioanalytical services market is facing increasing demand in the biotechnology and pharmaceutical industry. The demand is increasing due to the difficulties in conducting these services in-house.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Historical Period | 2017-2021 |
Unit | Value (USD Million) |
Key Companies Profiled | Charles River Laboratories International Inc. (United States), LabCorp (United States), WuXi PharmaTech (Cayman) Inc. (China), IQVIA (United States), Eurofins Scientific SE (Luxembourg), Syneos Health (United States), SGS (Switzerland), PPD Inc. (United States), PRA Health Sciences (United States) and BioReliance Corporation (United States) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region or narrow down segments in the final scope subject to feasibility |
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics of major and emerging geographies across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Key Players of Bioanalytical Services Market Study:
Charles River Laboratories International Inc. (United States), LabCorp (United States), WuXi PharmaTech (Cayman) Inc. (China), IQVIA (United States), Eurofins Scientific SE (Luxembourg), Syneos Health (United States), SGS (Switzerland), PPD Inc. (United States), PRA Health Sciences (United States) and BioReliance Corporation (United States)
Bioanalytical Services Market Segment Analysis
Scope | Sub-Segments |
---|
Application / End User | Pharmaceutical Industry, Biotechnology and Medical Device Industry |
Type | Discovery bioanalysis services, Non-clinical bioanalysis services and Clinical bioanalysis services |
Molecule | Small molecules,Large molecules |
Test | ADME {absorption, distribution, metabolism, and excretion},Pharmacokinetic,Pharmacodynamics,Bioavailability,Bioequivalence,Others |
Influencing Trend:
Increase in investment by biopharmaceutical companies in R&D and drug development and Rising trend of outsourcing analytical testing owing to cost effective than in-house R&D
Market Growth Drivers:
Increasing demand for bioanalytical services in the pharmaceutical and biotechnology industry and Increase in incidence of chronic diseases and rise in economic cost
Challenges:
Expensive treatments
Restraints:
Lack of skilled professionals to carry out activities
Opportunities:
Burden of these diseases on health care systems across the world
Some of the other players that are also part of study are Bioclin Research Laboratories, Intertek Group Plc., ICON, Algorithme and Parexel.
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Bioanalytical Services market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Bioanalytical Services market.
Identification of total players or companies operating in the global market which is further concentrated to fewer or most impacting players which are considered under the reports scope. In order to make a priority list sorting is done based on revenue generated based on the latest reporting with the help of paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Healthcare Institutions (Hospitals, Medical Schools, and outpatient Clinics), Biopharmaceutical companies, Contract development and manufacturing organization (CDMO), Clinical Research organizations/ contract research organizations, Market Research and Consulting Firms and Venture Capitalists and Investors.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.